Related Experiment Videos
Pulmonary embolism and cardiac enzymes
Nazim Uddin Azam Khan1, Assad Movahed
1Division of Cardiology, Department of Medicine, East Carolina University Brody School of Medicine, Pitt County Memorial Hospital, Greenville, North Carolina 27858, USA.
Heart & Lung : the Journal of Critical Care
|March 12, 2005
Summary
This study found no significant link between pulmonary embolism (PE) and elevated cardiac enzymes, even in patients with chest pain. Right ventricular dysfunction also did not correlate with chest pain in PE patients.
Area of Science:
- Cardiology
- Pulmonology
- Diagnostic Imaging
Background:
- Pulmonary embolism (PE) can present with chest pain, ECG changes, and right ventricular (RV) dysfunction.
- Elevated troponin levels have been reported in PE, indicating potential prognostic implications.
- The relationship between PE, cardiac enzymes, and chest pain requires further investigation.
Purpose of the Study:
- To investigate the association between pulmonary embolism (PE) and elevated cardiac enzymes.
- To determine if chest pain influences the relationship between PE and cardiac enzyme levels.
- To explore the correlation between RV dysfunction and chest pain in PE patients.
Main Methods:
- Retrospective analysis of 93 patients with high-probability ventilation/perfusion lung scans for PE.
- Assessment of chest pain, cardiac enzyme levels, and echocardiographic evidence of RV dysfunction.
- Comparison of findings between patients with and without chest pain.
Main Results:
- Only 1 out of 56 patients evaluated had abnormal cardiac enzymes; this patient had a history of coronary artery disease (CAD) and myocardial infarction.
- No significant relationship was found between RV dysfunction and chest pain (P > .10).
- No significant association between PE and abnormal cardiac enzymes, regardless of chest pain presence.
Conclusions:
- High-probability PE on V/Q scans is not significantly associated with abnormal cardiac enzymes.
- Chest pain occurrence in PE patients is not linked to the presence of RV dysfunction or a history of CAD.
- Cardiac enzyme evaluation in PE may not be significantly impacted by chest pain presentation.